BMED vs THNR: which is really different?

BMED and THNR hold 16% of their weight in the same names, and BMED returned +29.3% over the year. iShares Health Innovation Active ETF and Amplify Weight Loss Drug & Treatment ETF.

61.5%
BMED in the S&P 500
39.5%
THNR in the S&P 500
+29.3%
BMED total return, 1 year
+9.2%
THNR total return, 1 year
BMED · 1 year to Sep 30, 202639% of its weight is outside the S&P 500
39% of its weight is outside the S&P 50062% of BMED's weight is in S&P 500 companies and 39% is outside the index62%39%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 96% · top ten 43% of the fund · 60 holdings filed Sep 30, 2026 · Nasdaq-100: 13% in39% of its weight is outside the S&P 50062% of BMED's weight is in S&P 500 companies and 39% is outside the index62%39%in the S&P 500outsideactive share 96% · top ten 43% of the fund

62% of BMED's weight is in S&P 500 companies and 39% is outside the index

THNR · 1 year to Sep 30, 202661% of its weight is outside the S&P 500
61% of its weight is outside the S&P 50040% of THNR's weight is in S&P 500 companies and 61% is outside the index40%61%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 97% · top ten 60% of the fund · 22 holdings filed Oct 1, 2026 · Nasdaq-100: 15% in61% of its weight is outside the S&P 50040% of THNR's weight is in S&P 500 companies and 61% is outside the index40%61%in the S&P 500outside the S&P 500active share 97% · top ten 60% of the fund

40% of THNR's weight is in S&P 500 companies and 61% is outside the index

ETFIQ Off-Index Score · THNR scores higherHow much of it is not the index it is sold as an alternative to?
0.1, the lowest in this set92.0, the highest

A percentile among the 375 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it → How it is computed →

What they hold in common

By the books each fund has filed, BMED and THNR hold 16% of their money in the same securities at the same weight. Above 50%, holding both is close to holding one of them twice. Holdings dated Oct 1, 2026 and Sep 30, 2026.

half

16% in common

Positions both hold, largest shared weight first
Holding BMED THNR
ABBVIE 4.61% 4.56%
GILEAD SCIENCES 5.00% 4.55%
MERCK & CO INC 3.10% 4.55%
AMGEN INC 2.45% 5.75%
PFIZER 1.52% 5.38%
Only in BMED
DANAHER 5.19%
MODERNA 5.19%
THERMO FISHER SCIENTIFIC INC 4.41%
JOHNSON & JOHNSON 4.17%
IQVIA HOLDINGS 3.75%
WATERS CORP 3.66%
BIOGEN 3.52%
VERTEX PHARMACEUTICALS 3.35%
Only in THNR
Eli Lilly & Co 10.07%
Novo Nordisk A/S 8.42%
CSPC Pharmaceutical Group Ltd 5.82%
Innovent Biologics Inc 5.30%
AstraZeneca PLC 5.27%
Regeneron Pharmaceuticals Inc 4.64%
Roche Holding AG 4.56%
Viking Therapeutics Inc 4.55%

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed.

16% of the two portfolios are the same securities at the same weight.

Performance, window by window

Total returnvs the S&P 500vs the Nasdaq-100
WindowBMEDTHNRBMEDTHNRBMEDTHNR
3 months+12.6%−1.8%+10.1 pts−4.3 pts+10.5 pts−3.9 pts
6 months+19.4%+0.7%+2.4 pts−16.3 pts−7.5 pts−26.1 pts
1 year+29.3%+9.2%+13.6 pts−6.5 pts+5.5 pts−14.6 pts
3 years+54.5%not published−30.5 ptsnot published−55.5 ptsnot published
Since launch
BMED Oct 2020 · THNR May 2024
+35.9%+1.6%−109.5 pts−46.1 pts−135.6 pts−62.8 pts

BMED and THNR over each window. Every figure is an ETFIQ calculation with distributions reinvested. Source: ETFIQ. Open the live comparison on ETFIQ →

On the same fields

BMED
iShares Health Innovation Active ETF · Holds 60 stocks in healthcare innovation and GLP-1, 62% of its weight in S&P 500 companies
THNR
Amplify Weight Loss Drug & Treatment ETF · Holds 22 stocks in healthcare innovation and GLP-1, 40% of its weight in S&P 500 companies
Issuer iShares Amplify
Theme Healthcare innovation and GLP-1 Healthcare innovation and GLP-1
In the S&P 500 61.5% 39.5%
Active share vs the S&P 500 95.6% 96.5%
In the Nasdaq-100 13.2% 14.9%
Holdings 60 22
Top ten, share of the fund 42.9% 59.8%
Expense ratio 0.55% 0.59%
Fee for the differing part 0.58% 0.61%
Total return, 1 year +29.3% +9.2%
vs the S&P 500 +13.6 pts −6.5 pts
vs the Nasdaq-100 +5.5 pts −14.6 pts
Below its high −1.0% −9.9%
Net assets $14m $6m

BMED and THNR on the same fields, as of Sep 30, 2026. Source: ETFIQ.

BMED in plain words

By weight, 62% of BMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 96%. The top ten holdings are 43% of the fund across 60 positions, as published by its issuer for Sep 30, 2026. Over the year to Sep 30, 2026 the fund returned +29.3% with distributions reinvested against +15.7% for the S&P 500, so a holder was ahead by 13.6 pts.

THNR in plain words

By weight, 40% of THNR's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 96%. The top ten holdings are 60% of the fund across 22 positions, as published by its issuer for Oct 1, 2026. Over the year to Sep 30, 2026 the fund returned +9.2% with distributions reinvested against +15.7% for the S&P 500, so a holder was behind by 6.5 pts. It sits 9.9% below its all-time high of Aug 25, 2026.

Questions people ask

Do BMED and THNR hold the same stocks?
By their latest filings, 16% of their books are the same securities at the same weight, which is mostly different names. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, BMED or THNR?
BMED has 62% of its weight in S&P 500 names and THNR has 40%, so THNR differs more from the index.
Which is cheaper, BMED or THNR?
BMED charges 0.55% a year and THNR charges 0.59%, so BMED is cheaper. Fees come from each fund's prospectus.
Cite this page

ETFIQ, BMED against THNR, data as of Sep 30, 2026. https://etfiq.com/compare/themes/bmed-vs-thnr

Open data

Free to use with attribution. Every figure is calculated from a named public source; the method is at etfiq.com/methodology.